EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lactylation‐Driven YTHDC1 Alleviates MASLD by Suppressing PTPN22‐Mediated Dephosphorylation of NLRP3

Feng Zhang, Linghua Zeng, Kunkun Zou, Keying Lin, Fangting Yao, Jinglun Song, Shumeng Zhang, Hanshu Feng, Zhichao Yang, Chunlei Wang, Hongtao Diao, Xue Kong und 5 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202510192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Feng Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150086, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Fatty Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction‐associated steatotic liver disease (MASLD) is among the most prevalent chronic liver diseases worldwide. The expression of YTH domain‐containing protein 1 (YTHDC1) is significantly reduced in patients and mouse models with MASLD. Hepatocyte‐specific knockout of YTHDC1 exacerbates HFD‐induced hepatic lipid accumulation. Lactate accumulation and enhanced arginyl‐tRNA synthetase 1 (AARS1)‐mediated K565‐specific lactylation are shown to drive the ubiquitination‐mediated degradation of YTHDC1. This work proposes that under MASLD conditions, diminished YTHDC1‐LDHA binding elevates free LDHA levels, which enhances YTHDC1 lactylation and suppresses its expression. This creates a positive feedback loop that exacerbates the progression of MASLD. Mechanistically, protein tyrosine phosphatase nonreceptor type 22 (PTPN22), identified as a downstream target of YTHDC1, exacerbates hepatic inflammation and lipid accumulation by dephosphorylating and activating NLRP3 at tyrosine 861, which in turn promotes the release of IL‐1β and IL‐18. Furthermore, mebendazole, a small‐molecule drug targeting YTHDC1, significantly alleviates MASLD. In conclusion, YTHDC1 mitigates MASLD by inhibiting the PTPN22‐mediated dephosphorylation and activation of NLRP3, offering new insights into therapeutic strategies for MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinFatty LiverAnimalsMiceHumansPhosphorylationMice, KnockoutMice, Inbred C57BLDisease Models, AnimalLiverMale

Stichwörter der Autor:innen

MASLDNLRP3PTPN22YTHDC1lactylation

Substanzen

NLR Family, Pyrin Domain-Containing 3 Protein

Autor:innen und Institutionen

  • General Surgery Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150086, China.
  • Department of Pharmacology (State Key Laboratory of Frigid Zone Cardiovascular Diseases, the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of…
  • Department of Minimal Invasive Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China.
  • Natural Product Applied Science, KIST School, University of Science & Technology (UST), Gangneung, 25451, Republic of Korea.
  • The Academician Cooperative Laboratory of Basic and Translational Research on Chronic Diseases, The First Affiliated Hospital, Jinan University, Guangzhou, 510632, China.

ORCID-Profile: Yu Bian

Förderung

  • National Natural Science Foundation of China
  • Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province

Zitieren

APA

Zhang, F., Zeng, L., Zou, K., Lin, K., Yao, F., Song, J., Zhang, S., Feng, H., Yang, Z., Wang, C., Diao, H., Kong, X., Pan, T., Kim, J., Duo, T., Li, L., & Bian, Y. (2026). Lactylation‐Driven YTHDC1 Alleviates MASLD by Suppressing PTPN22‐Mediated Dephosphorylation of NLRP3. Advanced Science. https://doi.org/10.1002/advs.202510192

Vancouver

Zhang F, Zeng L, Zou K, Lin K, Yao F, Song J, et al. Lactylation‐Driven YTHDC1 Alleviates MASLD by Suppressing PTPN22‐Mediated Dephosphorylation of NLRP3. Advanced Science. 2026. doi:10.1002/advs.202510192

BibTeX
@article{Zhang2026,
  author = {Zhang, Feng and Zeng, Linghua and Zou, Kunkun and Lin, Keying and Yao, Fangting and Song, Jinglun and Zhang, Shumeng and Feng, Hanshu and Yang, Zhichao and Wang, Chunlei and Diao, Hongtao and Kong, Xue and Pan, Tengfei and Kim, Joonki and Duo, Tianqi and Li, Linqiang and Bian, Yu},
  title = {Lactylation‐Driven YTHDC1 Alleviates MASLD by Suppressing PTPN22‐Mediated Dephosphorylation of NLRP3},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202510192}
}
Kostenlos starten →